Collaboration with drug industry won’t affect clinical decisions, says new guide

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e2489 (Published 2 April 2012)
Cite this as: BMJ 2012;344:e2489

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Clare Dyer
  1. 1BMJ

Doctors are being urged not to be “tempted to accept the negative myths about cooperating with industry” in a new guide to promote collaboration between healthcare organisations and the drug industry to improve care of patients in the United Kingdom.

The guidance is supported by organisations representing the industry and by healthcare bodies including the BMA, the Academy of Medical Royal Colleges, and the royal colleges of GPs, physicians, and psychiatrists. The Department of Health for England, the NHS Confederation, and the governments of Scotland and Wales also back the guide, which is aimed at …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL